Pharma/Fine Chemicals Roundup – October 25

SALTIGO TO BUILD POTENT API FACILITY IN U.S. Custom synthesis firm Saltigo (Langenfeld, Germany), a Lanxess subsidiary, says it will build new production capacities for potent active pharmaceutical ingredients (API) at its Redmond, WA site, to supply the American pharmaceutical industry. Potent and highly potent APIs of categories III and IV as defined by the SafeBridge system already play a key role among the low-molecular-weight active ingredients, and this trend will continue to increase in the future, Saltigo says. Such substances can be administered in lower...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers